A 32-year-old healthcare worker presents to A&E with a three-week history of night sweats, weight loss, and productive cough. Simultaneously, a 19-year-old university student arrives by ambulance with a two-hour history of severe headache, photophobia, and altered consciousness. Both scenarios represent notifiable diseases requiring immediate public health intervention. Understanding the statutory frameworks surrounding and is fundamental to preventing secondary transmission and ensuring appropriate infection control measures are implemented without delay.
Tuberculosis (TB) - Key Definitions:
Active TB disease: Symptomatic infection with viable Mycobacterium tuberculosis, confirmed by culture, PCR, or strong clinical/radiological evidence
Latent TB infection (LTBI): Asymptomatic state with positive IGRA/TST but no active disease
UK epidemiology (2022 data):
Meningitis - Key Definitions:
Bacterial meningitis: Inflammation of meninges caused by bacterial pathogens
UK epidemiology:
Statutory Notification Requirements:
| Disease | Notification Trigger | Timeframe | Responsible Clinician |
|---|---|---|---|
| Active TB (all forms) | Clinical suspicion (before confirmation) | Within 3 working days | Any registered medical practitioner |
| Meningitis (bacterial) | Clinical suspicion | Immediate (same day) | Any registered medical practitioner |
| Meningococcal septicaemia | Clinical suspicion | Immediate (same day) | Any registered medical practitioner |
📌 Mnemonic for Notifiable Diseases: "TB Means Call Health Protection" - Tuberculosis, Meningitis, Cholera, Hepatitis, Plague (covers major notifiable infections)


The journey from exposure to clinical disease in and involves complex host-pathogen interactions that determine infection outcomes. Understanding these mechanisms explains why certain populations develop severe disease while others remain asymptomatic, and why treatment strategies target specific stages of the infectious process.
TB Transmission and Infection Dynamics:
Airborne transmission: Droplet nuclei (1-5 μm) containing 1-3 bacilli remain suspended for hours
Primary infection sequence:
Reactivation risk factors (quantified):
Meningitis Pathogenesis:
Bacterial invasion routes:
BBB disruption cascade:
Complications mechanisms:
A 45-year-old man from Bangladesh presents with six weeks of productive cough, haemoptysis, and 8 kg weight loss. Chest X-ray shows right upper lobe consolidation with cavitation. Meanwhile, a 21-year-old student develops fever, severe headache, and neck stiffness over four hours, with a non-blanching purpuric rash on her legs. These presentations demand immediate, systematic diagnostic approaches following evidence-based algorithms as outlined in and .
TB Diagnostic Pathway (NICE NG33):
Clinical assessment priorities:
Investigations sequence:
Meningitis Diagnostic Pathway (NICE NG240):
Clinical assessment (immediate):
Investigations sequence:
| CSF Parameter | Bacterial | Viral | TB |
|---|---|---|---|
| Opening pressure | >25 cmH₂O | Normal | >25 cmH₂O |
| WCC (cells/μL) | 100-10,000 (neutrophils >80%) | 10-1,000 (lymphocytes >50%) | 10-500 (lymphocytes >50%) |
| Protein (g/L) | >1.0 | 0.4-0.8 | 1.0-5.0 |
| Glucose (CSF:serum ratio) | <0.4 | >0.6 | <0.5 |
| Gram stain sensitivity | 60-90% | N/A | <20% (Ziehl-Neelsen) |
🚩 Red Flag: Do NOT delay antibiotics for LP. If meningococcal disease suspected, give IV benzylpenicillin 1.2 g (or ceftriaxone 2 g) immediately, even in community settings.


Differentiating from other chronic respiratory infections and from alternative causes of acute encephalopathy requires systematic analysis of discriminating features. Cognitive errors-particularly anchoring bias (fixating on initial diagnosis) and premature closure (stopping diagnostic workup too early)-account for 30-40% of missed diagnoses in serious infections.
TB Differential Analysis:
| Feature | Pulmonary TB | Bacterial Pneumonia | Lung Cancer | Fungal Infection |
|---|---|---|---|---|
| Onset | Subacute (weeks-months) | Acute (days) | Insidious (months) | Subacute (weeks) |
| Fever pattern | Low-grade, night sweats | High-grade, rigors | Low-grade or absent | Intermittent |
| Haemoptysis | Streaky (20%) | Rusty sputum (30%) | Frank blood (40%) | Rare |
| CXR distribution | Upper lobe, cavitation | Lobar consolidation | Mass ± lymphadenopathy | Nodules, halo sign |
| Sputum smear | AFB positive | Gram stain organisms | Cytology: malignant cells | KOH prep: hyphae |
| Response to antibiotics | None (standard) | Rapid (48-72h) | None | None (standard) |
Key discriminators for TB:
Meningitis Differential Analysis:
| CSF Feature | Bacterial | Viral | TB | Fungal (Cryptococcal) |
|---|---|---|---|---|
| Onset | Hours | Days | Weeks | Weeks |
| Glucose | <2.2 mmol/L | Normal | <2.2 mmol/L | <2.2 mmol/L |
| Protein | >1.0 g/L | <0.8 g/L | 1.0-5.0 g/L | >1.0 g/L |
| Neutrophils | >80% | <50% | <50% (early may be neutrophilic) | <20% |
| Specific tests | Gram stain, PCR | Viral PCR | AFB, TB PCR | India ink, antigen |
| Lactate | >4 mmol/L | <2 mmol/L | >4 mmol/L | Variable |
Common diagnostic pitfalls:
⭐ Clinical Pearl: CSF lactate >3.5 mmol/L distinguishes bacterial from viral meningitis with 93% sensitivity and 96% specificity-more reliable than glucose or protein alone in partially treated cases.
The management of and exemplifies the principle of "time-to-treatment determines outcome." For bacterial meningitis, every hour delay in antibiotic administration increases mortality by 8%. For TB, early treatment prevents transmission (patients become non-infectious within 2 weeks of appropriate therapy) and reduces mortality from 50% (untreated) to <5% (treated). NICE guidelines emphasize immediate empirical therapy while awaiting microbiological confirmation.
TB Treatment (NICE NG33):
Standard regimen (drug-sensitive TB):
Monitoring requirements:
MDR-TB treatment (resistance to rifampicin + isoniazid):
Meningitis Treatment (NICE NG240):
Empirical therapy (immediate):
Adjunctive dexamethasone:
| Organism | Targeted Antibiotic | Duration | Additional Therapy |
|---|---|---|---|
| N. meningitidis | Ceftriaxone 2 g IV 12-hourly | 7 days | Dexamethasone 4 days |
| S. pneumoniae | Ceftriaxone 2 g IV 12-hourly | 14 days | Dexamethasone 4 days |
| Listeria | Amoxicillin 2 g IV 4-hourly + Gentamicin 7 mg/kg IV daily | 21 days | No steroids |
| M. tuberculosis | RHZE (as above) | 12 months | No dexamethasone |
🚩 Red Flag: Never delay antibiotics for imaging or LP. Mortality increases 8% per hour without treatment. Administer ceftriaxone within 60 minutes of hospital arrival.
Real-world management of and frequently involves patients with multimorbidity, immunosuppression, or drug resistance. These scenarios demand synthesis of multiple guidelines, specialist input, and individualised risk-benefit analysis. Recent evidence emphasises the importance of multidisciplinary team (MDT) involvement for optimal outcomes.
TB in Special Populations:
HIV co-infection (CD4 <200 cells/μL):
Pregnancy:
Chronic kidney disease (eGFR <30 mL/min):
MDR-TB Management:
Regimen construction principles:
Adverse effect monitoring:
Meningitis Complications:
Raised ICP management:
Seizure management:
| Complication | Incidence | Management | Outcome Impact |
|---|---|---|---|
| Cerebral oedema | 60-80% | Hypertonic saline, head elevation | Mortality 30% if severe |
| Seizures | 20-30% | Levetiracetam 1000 mg IV | Doubles mortality risk |
| Hearing loss | 10-30% | Dexamethasone (preventive) | Permanent in 50% |
| Hydrocephalus | 15-25% | EVD if symptomatic | Requires long-term shunt in 30% |
⭐ Clinical Pearl: In MDR-TB, therapeutic drug monitoring (TDM) improves culture conversion rates by 20-30%. Target peak levels: levofloxacin 8-12 mg/L, linezolid 2-7 mg/L.
Key Take-Aways:
Essential Numbers/Formulas:
| Parameter | Critical Value | Clinical Significance |
|---|---|---|
| TB sputum conversion | 2 months | 90% should be culture-negative; failure indicates resistance |
| CSF glucose (bacterial) | <2.2 mmol/L or ratio <0.4 | Sensitivity 80%, specificity 98% |
| CSF WCC (bacterial) | >100 cells/μL (>80% neutrophils) | Distinguishes from viral (lymphocytic) |
| Meningitis antibiotic window | <60 minutes from arrival | Each hour delay = 8% mortality increase |
| TB cavitation infectivity | 10⁵-10⁷ bacilli/mL sputum | Highly infectious until 2 weeks treatment |
| Dexamethasone NNT | 10 | Prevents 1 death/severe disability in pneumococcal meningitis |
Key Principles/Pearls:
Quick Reference:
| Clinical Scenario | Immediate Action | Key Investigation | Definitive Treatment |
|---|---|---|---|
| Suspected meningococcal disease | Benzylpenicillin 1.2 g IV or ceftriaxone 2 g IV | Blood cultures, LP if no contraindications | Ceftriaxone 2 g IV 12-hourly × 7 days |
| Cavitary pulmonary TB | Respiratory isolation | 3× sputum for AFB, culture, GeneXpert | RHZE × 2 months → RH × 4 months |
| TB in HIV (CD4 <50) | Start TB treatment immediately | Baseline CD4, viral load, drug resistance | Standard RHZE + ART within 2 weeks |
| MDR-TB confirmed | Specialist TB centre referral | Drug susceptibility testing, TDM | ≥5 drugs (bedaquiline, linezolid, fluoroquinolone) × 18-24 months |
</budget:token_budget>
Test your understanding with these related questions
A 58-year-old woman with diabetes presents with severe foot pain and a deep ulcer exposing bone. X-ray shows osteolytic changes. What is the most likely complication?
Get full access to all lessons, practice questions, and more.
Start Your Free Trial